innovation

Siemens recently unveiled an imaging device that promises to detect diseases earlier, allowing for earlier treatment to improve the outlook for patients.

Researchers are looking into drone delivery as a method to efficiently deliver testing kits while limiting contact between individuals.

Through cutting-edge technology, Texas A&M nursing students gain clinical experience before working directly with patients.

Sano Chemicals, founded by Professor of Biology Jim Smith, is focused on treating drug-resistant fungal and bacterial infections.

The Worlds Protect breathalyzer kiosk uses artificial intelligence to “smell” or detect COVID-19 on an exhaled breath. The next step is to make this technology more accessible.

The drug developed by Texas A&M and University of Texas MD Anderson Cancer Center scientists could be an effective treatment for COVID-19 and other illnesses.

A Texas A&M researcher and students hope to harness the thermal energy generated by body heat to power a small, electronic device capable of detecting fever in the wearer.

The study could be the first step toward creating portable systems for home use that can change oxygen supply depending on a patient’s needs.

The team will develop a platform to rapidly prototype and test thermally stable and highly efficient mRNA vaccines.

Texas A&M research shows exposure to high temperatures can neutralize the virus, preventing it from infecting another human host.